4.37
1.13%
-0.05
Handel nachbörslich:
4.37
Finanzdaten der Adaptive Biotechnologies Corp-Aktie (ADPT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
8.54%
41.87
|
45.78 | 37.92 | 48.93 | 37.65 |
Cost Of Revenue |
7.98%
18.05
|
19.62 | 19.35 | 17.91 | 18.68 |
Gross Profit |
8.97%
23.82
|
26.17 | 18.57 | 31.02 | 18.97 |
Operating Expenses
|
25.35%
72.58
|
97.24 | 69.53 | 78.83 | 76.16 |
Interest Income/Expense |
0.63%
2.993
|
3.012 | 3.652 | 3.605 | 3.531 |
Benefits Costs and Expenses |
22.42%
89.41
|
115.25 | 88.25 | 96.74 | 95.35 |
Costs And Expenses |
22.44%
90.64
|
116.85 | 88.88 | 96.74 | 94.84 |
Depreciation and Amortization |
5.214
|
- | - | - | - |
Operating Income/Loss |
31.39%
-48.76
|
-71.07 | -50.96 | -47.82 | -57.19 |
Income/Loss From Continuing Operations Before Tax |
31.57%
-47.53
|
-69.47 | -50.33 | -47.81 | -57.70 |
Income/Loss From Continuing Operations After Tax |
31.57%
-47.53
|
-69.47 | -50.33 | -47.81 | -57.70 |
Net Income/Loss
|
31.57%
-47.53
|
-69.47 | -50.33 | -47.81 | -57.70 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
0.00%
-0.026
|
-0.026 | -0.026 | -0.001 | -0.001 |
Basic Average Shares |
83,516%
145.79
|
0.1744 | 144.70 | 144.40 | 143.51 |
Diluted Average Shares |
83,516%
145.79
|
0.1744 | 144.70 | 144.40 | 143.51 |
Basic Earnings Per Share |
31.25%
-0.33
|
-0.48 | -0.35 | -0.33 | -0.40 |
Diluted Earnings Per Share |
31.25%
-0.33
|
-0.48 | -0.35 | -0.33 | -0.40 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):